Bayer Wants More Fraud Claims Nixed In Trasylol MDL

Law360, New York (March 31, 2009, 12:00 AM EDT) -- Bayer AG has asked a judge to expand his dismissal of fraud claims in three suits to include others in the multidistrict litigation over the blood-clotting drug Trasylol, which Bayer pulled from the market after studies indicating potentially fatal side effects came to light.

Bayer on Monday requested that a March 5 order dismissing common law fraud claims in three individual complaints and a constructive fraud claim in the master complaint be applied to those claims in other cases before the United States District Court for...
To view the full article, register now.




Case Information

Case Title

IN RE: Trasylol Products Liability Litigation

Case Number



Florida Southern

Nature of Suit

Personal Inj. Prod. Liability


Donald M. Middlebrooks

Date Filed

April 7, 2008

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.